USMLE Oncology Practice Questions with Answers

Concept Explanation

USMLE Oncology is a multidisciplinary domain that integrates pathology, pharmacology, and clinical medicine to diagnose and manage neoplastic diseases. At its core, the field focuses on the molecular mechanisms of carcinogenesis, the clinical presentation of solid and hematologic malignancies, and the mechanism of action of chemotherapeutic agents. Understanding the cell cycle, proto-oncogenes, and tumor suppressor genes is vital for success on the exam. For example, a mutation in the TP53 gene, which normally regulates the G1-S phase transition, is found in more than 50% of human cancers and is a high-yield topic for those pursuing USMLE Prep. Clinically, students must differentiate between paraneoplastic syndromes, such as SIADH in small cell lung cancer or hypercalcemia in squamous cell lung cancer, and identify the side effect profiles of drugs like doxorubicin or bleomycin. Knowledge of staging (TNM system) and the use of tumor markers like CA-125 or PSA further rounds out the essential knowledge base for medical licensing exams.

Solved Examples

1. Paraneoplastic Syndrome Identification
   A 65-year-old male with a 40-pack-year smoking history presents with a cough and recent weight loss. Laboratory studies show a serum sodium of 122 mEq/L and high urine osmolarity. Chest X-ray reveals a central hilar mass. What is the most likely diagnosis?
   
   1. Identify the clinical findings: Hyponatremia with high urine osmolarity indicates Syndrome of Inappropriate Antidiuretic Hormone (SIADH).
   2. Link the syndrome to the cancer type: SIADH is most commonly associated with small cell lung cancer (SCLC).
   3. Confirm the location: SCLC typically presents as a central hilar mass in smokers.
   4. Answer: Small cell lung carcinoma.
2. Chemotherapy Mechanism of Action
   A patient undergoing treatment for Hodgkin lymphoma develops pulmonary fibrosis. Which medication in the ABVD regimen is most likely responsible?
   
   1. Recall the ABVD regimen components: Adriamycin (Doxorubicin), Bleomycin, Vinblastine, and Dacarbazine.
   2. Match toxicities: Doxorubicin causes cardiotoxicity; Vinblastine causes bone marrow suppression.
   3. Identify the specific lung toxin: Bleomycin is known for inducing free radical damage that leads to pulmonary fibrosis.
   4. Answer: Bleomycin.
3. Tumor Suppressor Genetics
   A 4-year-old child presents with a white pupillary reflex (leukocoria) in the left eye. Genetic testing reveals a mutation on chromosome 13. What is the physiological role of the protein encoded by the affected gene?
   
   1. Diagnose the condition: Leukocoria in a child suggests Retinoblastoma.
   2. Identify the gene: Retinoblastoma is caused by a mutation in the RB1 gene on chromosome 13.
   3. Determine the function: The Rb protein inhibits the E2F transcription factor, preventing the cell from progressing from the G1 to the S phase.
   4. Answer: Inhibition of the E2F transcription factor to regulate the G1/S checkpoint.

Practice Questions

1. A 58-year-old female with breast cancer is started on a medication that inhibits the enzyme aromatase. This treatment is primarily used in postmenopausal women to decrease the peripheral conversion of androgens to what substance?
2. A 30-year-old male presents with a painless testicular mass. Laboratory tests show elevated levels of alpha-fetoprotein (AFP) and beta-hCG. Which germ cell tumor is most likely?
3. During a pathology review, a biopsy of a thyroid nodule shows cells arranged in follicles with "Orphan Annie eye" nuclei and psammoma bodies. What is the most likely diagnosis?

4. A patient with metastatic colorectal cancer is treated with 5-fluorouracil (5-FU). This drug works by inhibiting which enzyme, leading to a "thymineless death" of the cell?
5. A 60-year-old male with chronic myeloid leukemia (CML) is prescribed Imatinib. Imatinib works by targeting the product of the $t(9;22)$ translocation, which possesses what type of enzymatic activity?
6. A 45-year-old woman with a history of heavy menses and an enlarged, irregular uterus undergoes a hysterectomy. Pathology reveals a malignant tumor of smooth muscle origin. What is the name of this malignancy?
7. Which monoclonal antibody targets the HER2/neu (erbB2) receptor and is frequently used in the treatment of specific subtypes of breast cancer?
8. A patient presents with high-grade fever, night sweats, and painless cervical lymphadenopathy. A lymph node biopsy reveals Reed-Sternberg cells. What is the characteristic immunophenotype (CD markers) of these cells in the classic form of this disease?
9. A 70-year-old male smoker presents with painless hematuria. Cystoscopy reveals a tumor in the bladder. Exposure to which industrial chemical is a known risk factor for transitional cell carcinoma of the bladder?
10. In the context of tumor lysis syndrome, which electrolyte abnormality is most likely to cause cardiac arrhythmias?

Answers & Explanations

1. Estrogen: Aromatase inhibitors (like Anastrozole) prevent the conversion of androstenedione to estrone and testosterone to estradiol in peripheral tissues, which is the primary source of estrogen in postmenopausal women.
2. Yolk Sac Tumor (or Mixed Germ Cell Tumor): While pure seminomas do not produce AFP, yolk sac tumors are specifically associated with elevated AFP levels. Mixed tumors are also common.
3. Papillary Thyroid Carcinoma: The presence of Orphan Annie eye nuclei (large, clear nuclei) and psammoma bodies (laminated calcium deposits) is pathognomonic for papillary thyroid cancer.
4. Thymidylate Synthase: 5-FU is converted to 5-dFUMP, which covalently binds to folic acid and inhibits thymidylate synthase, stopping dTMP synthesis.
5. Tyrosine Kinase: The BCR-ABL fusion protein created by the Philadelphia chromosome translocation functions as a constitutively active tyrosine kinase.
6. Leiomyosarcoma: This is the malignant counterpart of a leiomyoma (fibroid) and arises de novo from smooth muscle cells in the myometrium.
7. Trastuzumab: Trastuzumab (Herceptin) is a monoclonal antibody that binds to the extracellular domain of the HER2 receptor, inhibiting downstream signaling.
8. CD15+ and CD30+: Classic Reed-Sternberg cells in Hodgkin lymphoma typically express CD15 and CD30 but are usually negative for the pan-B-cell marker CD20.
9. Beta-naphthylamine: This chemical, often found in cigarette smoke and used in the dye and rubber industries, is a classic high-yield risk factor for bladder cancer.
10. Hyperkalemia: Rapid lysis of tumor cells releases intracellular potassium into the bloodstream, which can lead to life-threatening peaked T-waves and arrhythmias.

1. A 55-year-old male with a history of asbestos exposure presents with pleuritic chest pain and a large pleural effusion. Biopsy shows calretinin-positive cells. What is the most likely diagnosis?

• ASmall cell lung cancer
• BSquamous cell lung cancer
• CMesothelioma
• DAdenocarcinoma

Frequently Asked Questions

What is the most common side effect of Vincristine?

The most notable side effect of Vincristine is peripheral neuropathy, which often presents as tingling or numbness in the hands and feet due to microtubule disruption in axons. Unlike many other chemotherapies, it is relatively "bone marrow sparing."

How do you distinguish between Hodgkin and Non-Hodgkin Lymphoma on a biopsy?

Hodgkin Lymphoma is characterized by the presence of Reed-Sternberg cells, which are large, multinucleated B-cells with "owl's eye" nucleoli. Non-Hodgkin Lymphoma involves a more diffuse or follicular proliferation of malignant B or T cells without these specific cells.

What is the clinical significance of a positive BRCA1 or BRCA2 mutation?

A mutation in these tumor suppressor genes significantly increases the lifetime risk of developing breast and ovarian cancers. Management often involves increased surveillance or prophylactic surgeries like bilateral salpingo-oophorectomy.

Which lung cancer is most common in non-smokers?

Adenocarcinoma is the most common type of lung cancer found in non-smokers and is typically located peripherally in the lung. It often arises from bronchial mucosal glands or alveolar epithelial cells.

What are the hallmarks of Tumor Lysis Syndrome?

Tumor Lysis Syndrome is characterized by the rapid breakdown of cancer cells leading to hyperuricemia, hyperkalemia, hyperphosphatemia, and secondary hypocalcemia. It is most commonly seen following the initiation of chemotherapy for high-turnover hematologic malignancies.